Recombinant Allergen Asp fl 3
Description
Definition and Biochemical Characteristics
Recombinant Allergen Asp f3 (rAsp f3) is a CCD-free, peroxiredoxin protein expressed via recombinant DNA technology. Key features include:
-
Molecular weight: 19 kDa, capable of forming dimers through disulfide bonds .
-
Function: Involved in fungal redox homeostasis, oxidative stress response, and iron metabolism .
-
Allergenic activity: Binds IgE antibodies in sensitized individuals, triggering type I hypersensitivity reactions .
Diagnostic Applications
rAsp f3 is widely used in serological and cutaneous testing to diagnose A. fumigatus sensitization and ABPA:
| Parameter | ABPA Patients | Non-ABPA Asthmatics | Healthy Controls |
|---|---|---|---|
| Prevalence of Sensitization | 70–84% | 45–58% | <2% |
| Median IgE Levels (kUA/L) | 0.74–10.7 | <0.35 | <0.35 |
-
Skin test reliability: 84% of A. fumigatus-sensitized asthmatics show positive skin reactions to rAsp f3, correlating strongly with serum IgE levels .
-
Diagnostic cut-offs: Population-specific thresholds improve accuracy (AUC: 0.728–0.968) .
Therapeutic Potential in Vaccination
rAsp f3 has demonstrated efficacy as a vaccine candidate against invasive aspergillosis:
Key Vaccine Constructs and Outcomes
| Variant | Adjuvant | Protection Efficacy | Antibody Response |
|---|---|---|---|
| Full-length rAsp f3(1-168) | TM | 60% survival | Strong IgG2a |
| Truncated rAsp f3(15-168) | None | 60% survival | Weak |
| Truncated rAsp f3(1-142) | TM | 60% survival | Weak |
-
Mechanism: Cellular immunity (likely T-cell-mediated) enhances macrophage function to clear fungal hyphae .
-
Cross-protection: Homologues in Candida and Penicillium species suggest broad applicability .
Cross-Reactivity with Other Fungi
rAsp f3 shares >80% sequence identity with peroxiredoxins from:
| Genus | Species | Clinical Relevance |
|---|---|---|
| Aspergillus | A. flavus, A. niger | Allergic sensitization |
| Candida | C. albicans | Cross-reactive IgE binding |
| Penicillium | P. chrysogenum | Occupational asthma |
Research Findings on Pathogenicity
-
Iron dependency: Asp f3 is essential for fungal growth under iron-limited conditions, a host defense mechanism .
-
Virulence: Deletion of aspf3 renders A. fumigatus avirulent in murine models .
-
Oxidative stress defense: Asp f3 null mutants show increased susceptibility to hydrogen peroxide .
Challenges and Limitations
-
Diagnostic variability: Sensitization prevalence varies by population and disease stage .
-
Vaccine optimization: Truncated variants reduce antibody production, necessitating adjuvant use .
Future Directions
Product Specs
Q&A
Basic Research Questions
How is recombinant Asp f3 produced and validated for immunological studies?
Recombinant Asp f3 is typically expressed in Escherichia coli or eukaryotic systems (e.g., insect cells) to ensure proper folding and post-translational modifications. Key steps include:
-
Cloning: Amplification of the aspf3 gene from Aspergillus fumigatus genomic DNA or cDNA.
-
Expression: Use of vectors with inducible promoters (e.g., pET, pPICZα) for cytoplasmic or secretory expression.
-
Purification: Affinity chromatography (e.g., Ni-NTA for His-tagged proteins) followed by size-exclusion chromatography to confirm monomeric state .
-
Validation:
What role does Asp f3 play in allergic bronchopulmonary aspergillosis (ABPA)?
Asp f3 acts as a major allergen by binding IgE antibodies, triggering mast cell degranulation and Th2-mediated inflammation. Methodological insights:
-
Epitope mapping: Synthetic peptides and deletion mutants identify IgE-binding regions (e.g., residues 1–12 and 143–150 are critical for conformational epitopes) .
-
Cellular assays: Peripheral blood mononuclear cells (PBMCs) from ABPA patients show IL-4/IL-5 secretion upon Asp f3 exposure .
What standard assays are used to evaluate Asp f3 immunogenicity?
-
Immunoblotting: Detects IgE reactivity to Asp f3 in crude fungal extracts .
-
Basophil activation test (BAT): Measures CD63 expression post-Asp f3 stimulation.
Advanced Research Questions
How do structural modifications of Asp f3 impact its allergenicity and vaccine potential?
Studies compare full-length Asp f3(1–168) with truncated variants (e.g., 15–168, 1–142):
-
Reduced IgE binding: Truncations at N/C-termini (e.g., Δ1–14 or Δ143–168) disrupt conformational epitopes, lowering IgE reactivity by 70% .
-
Enhanced Th1 responses: Subcutaneous immunization with Asp f3(15–142) in mice induces IgG2a (a Th1 marker) and reduces eosinophil infiltration .
Table 1: Immunogenicity of Asp f3 Variants in Murine Models
| Variant | IgE Reactivity | IgG2a Response | Protection Efficacy |
|---|---|---|---|
| Full-length | High | Moderate | 80% survival |
| Truncated (15–142) | Low | High | 95% survival |
| Truncated (1–142) | Moderate | Low | 65% survival |
| Data derived from . |
How to resolve contradictions in Asp f3’s role in fungal virulence?
While Asp f3 deletion attenuates A. fumigatus virulence in murine models , its peroxidase activity alone does not explain this phenotype. Key approaches:
-
Iron supplementation assays: Restoring iron availability rescues growth defects in Δaspf3 mutants, linking Asp f3 to iron homeostasis .
-
Redundancy analysis: Double mutants (Δaspf3 + Δaf3l1) show synthetic lethality under iron limitation, revealing functional overlap with homolog Af3l1 .
What novel methodologies improve Asp f3-specific diagnostic accuracy?
-
Recombinant multiplex assays: Combine Asp f3 with other allergens (e.g., Asp f1, f2) to reduce cross-reactivity in ELISA/ImmunoCAP .
-
CRISPR-edited epitopes: Mutating residues 143–150 in recombinant Asp f3 eliminates false-positive IgE binding in non-ABPA cystic fibrosis patients .
Mechanistic & Translational Questions
How does Asp f3 interact with host iron metabolism during infection?
Asp f3 compensates for iron-dependent antioxidant systems (e.g., catalases) under low-iron conditions:
-
Transcriptomic profiling: Δaspf3 shows downregulation of siderophore biosynthesis genes (sidA, mirB) .
-
ROS scavenging: Asp f3’s peroxiredoxin activity reduces H2O2 levels in vitro (IC50 = 2.5 μM) .
Can Asp f3-directed vaccines overcome corticosteroid-induced immunosuppression?
In murine models, Asp f3(15–142) vaccination:
-
Restores macrophage fungicidal activity by upregulating TNF-α and IFN-γ .
-
Reduces fungal burden by 4-log units in immunosuppressed hosts .
Data Interpretation Challenges
Why do some Asp f3 truncations enhance IgG2a but not IgG1 responses?
Hypothesis: Terminal deletions expose cryptic Th1 epitopes. Validation strategies:
-
T-cell epitope mapping: Overlapping peptides identify CD4+ epitopes in truncated regions.
-
Cytokine profiling: Truncated Asp f3 boosts IL-12/IFN-γ in dendritic cell cocultures .
How to address cross-reactivity between Asp f3 and environmental allergens?
-
B-cell receptor sequencing: Clonal overlap analysis identifies Asp f3-specific B cells in ABPA vs. pollen allergy cohorts.
-
Competitive ELISA: Pre-incubation with Alternaria Alt a3 inhibits 30% of IgE binding to Asp f3, suggesting partial epitope sharing .
Future Research Directions
Can Asp f3 be engineered for hypoallergenic immunotherapy?
-
Site-directed mutagenesis: Replace C-terminal residues 143–150 with non-immunogenic sequences (e.g., glycine linkers) .
-
Virus-like particle (VLP) conjugation: Display Asp f3 mutants on VLPs to enhance dendritic cell uptake and tolerogenic responses.
What systems biology approaches elucidate Asp f3’s multifunctionality?
-
Network modeling: Integrate proteomics (host-pathogen interactomes) and metabolomics (iron-ROS axis) data.
-
Single-cell RNA-seq: Identify Asp f3-responsive alveolar macrophage subsets in murine lungs.
